Clinical Trial: A Study of HT-101 and HT-102 in Chronic Hepatitis B (CHB)

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07917910) titled 'A Study of HT-101 and HT-102 in Chronic Hepatitis B (CHB)' on Oct. 29.

Brief Summary: Phase II trial of HT-101 + HT-102 in CHB: (1) functional cure in treatment-naive patients (vs placebo); (2) efficacy of sequential interferon in previously treated patients.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B Virus Infection

Intervention: DRUG: HT-101 + HT-102

HT-101 given by subcutaneous injection.HT-102 given by subcutaneous injection.

DRUG: HT-101 placebo + HT-102 placebo

HT-101 placebo + HT-102 placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou HepaThera Biotech Co., Ltd.

D...